PDT Partners’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
PDT Partners's TARS Position: Q3 2026 in Review
PDT Partners held its Tarsus Pharmaceuticals (TARS) position steady in Q3 2026 at 32,292 shares worth $2.54M. The position accounts for 0.14% of the portfolio, ranked #208.
PDT Partners first reported a position in TARS in Q2 2025 and has held it in 6 quarters since. The position peaked at $5.16M in Q4 2025. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- PDT Partners held 32,292 shares of Tarsus Pharmaceuticals worth $2.54M as of Q3 2026.
- PDT Partners left its Tarsus Pharmaceuticals share count unchanged in Q3 2026.
- Tarsus Pharmaceuticals made up 0.14% of PDT Partners's portfolio in Q3 2026, its #208 holding.
- PDT Partners first reported a position in Tarsus Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- PDT Partners's Tarsus Pharmaceuticals position peaked at $5.16M in Q4 2025.
- 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on PDT Partners's 13F filing for Q3 2026, filed 16 Nov 2026.